Our Company

Advancing human health by delivering life-changing therapies.

Since its inception in 2004, Tigermed (300347.SZ/3347.HK) has been a trusted clinical research organization that provides full-service for the global biopharmaceutical and medical device industries. We are devoted to serving our customers in their clinical development journey efficiently and cost-effectively. For twenty years, we have been accelerating the launch of innovative healthcare products with our quality, solutions, teams, experience, and expertise, to advance human health.

Global Employees
11,900+
Global Customers
4,200+
Global Offices and Locations
180+
Chinese Innovative Drugs Involved
210+

A Full Service CRO for Healthcare Innovation

Whether you are developing a small molecule or biologic, a vaccine or medical device, we have tailored solutions to move your research forward.

Small Molecule
Biologics
Cell & Gene Therapy
Medical Device
Rare Disease
Vaccine

A Global Presence

Tigermed represents a worldwide network of professional clinical experts. We have more than 100 subsidiaries and 180 offices and sites, with over 11,900 employees across a dozen of countries in Asia Pacific, Europe, North & South America and Africa.

Advance Human Health through Delivery Excellence

Watch Our Corporate Video

Learn more about Our History

Key Milestones of Corporate History

Tigermed

2004

MacroStat

2005

Jiaxing Tigermed

2010

Hangzhou SIMO

Tigermed Hong Kong

2011

IPO in Shenzhen Stock Exchange (300347.SZ)

Fantastic Imaging

2012

Talent

IntelliPV

Tigermed Australia

Tigermed Taiwan

Bioquick

2013

Frontage Lab

TigerYeah Capital

Clinflash

Canny Consulting

2014

DreamCIS

Beijing BDN

2015

Teddy Laboratory

Tigermed India

2016

Tigermed-Jyton

Tigermed Switzerland

2017

OperaCRO

2018

BRI Pharmaceutical & RMI Laboratories

Frontage IPO in HKSE (1521.HK)

Wuxi Tigermed

Yaxincheng

Tigermed America

2019

Listed in HKEX (3347.HK)

DreamCIS IPO in Korea

Mosim

Joint-venture Tigerise

2020

Global expansion to Latin America, Africa and Middle East

Support of CanSino COVID-19 vaccine

Hainan Tigermed

2021

New offices in Europe (UK, Netherlands)

New offices in APAC (Laos, Philippines)

2022

Marti Farm

International HQ in Hong Kong

2023

Medical Edge

2024

Micron Inc.

2025

Opening of new global HQ building in Hangzhou

Tigermed New Zealand

Acquisition of JetMed

2026

Customer Recognition is Our

Driving Force

From Our Customers

Product Approval Appreciation Award|Pfizer

Enrollment Contribution Award|AstraZeneca

Best Startup Award|Hua Medicine

Outstanding CRC Contribution Award|BeOne

Outstanding Service Award|MSD

Best Partnership Award|Allist

Excellent Teamwork Award|Hutchison

Trusted Partnership Award|Karl Storz

Best SMO Company|Cancer Hospital of Peking University

From the Industry

2026 LinkedIn Global Attractive Employer Award

2025 Forbes China Go-International Brand Top 30

2025 MSCI ESG AAA rating (the highest in the industry)

2025 Excellent Employer by ZHAOPIN China

2025 Leading CRO Award from PharmaCube

2025 Top100 Zhejiang Service Industry

2023 Best Employer Award by LinkedIn

2023 GlobalIN Top50 Companies in Technology